Greenwood Capital Associates’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-73,362
Closed -$5.09M 257
2023
Q3
$5.09M Buy
73,362
+2,554
+4% +$193K 0.74% 48
2023
Q2
$5.73M Buy
+70,808
New +$5.79M 0.8% 47
2017
Q4
Sell
-5,931
Closed -$218K 225
2017
Q3
$218K Sell
5,931
-2,670
-31% -$108K 0.05% 179
2017
Q2
$390K Sell
8,601
-4,809
-36% -$212K 0.1% 121
2017
Q1
$571K Buy
13,410
+5,900
+79% +$241K 0.15% 104
2016
Q4
$301K Buy
+7,510
New +$290K 0.09% 133

Other funds holding HOLX

Greenwood Capital Associates's HOLX Position: Q4 2023 in Review

Greenwood Capital Associates sold out of Hologic (HOLX) in Q4 2023, closing a stake of 73,362 shares — an estimated $5.09M sold.

Greenwood Capital Associates first reported a position in HOLX in Q4 2016 and held it in 6 quarters. The position peaked at $5.73M in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Greenwood Capital Associates reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Greenwood Capital Associates sold 73,362 Hologic shares in Q4 2023, an estimated $5.09M.
  • Greenwood Capital Associates first reported a position in Hologic in Q4 2016 and held it in 6 quarters.
  • Greenwood Capital Associates's Hologic position peaked at $5.73M in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.